Neurological Surgery Doctors in Abilene, TX Accepting Medicare

5 Neurological Surgery doctors found. Showing 1 - 5

Steven Wallace Brown, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1850 Hickory St, Suite 101, Abilene, TX 79601 Phone: 325-670-4730    Fax: 325-670-4736

Mark S Maxwell, DO Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1933 Pine St, Ste A, Abilene, TX 79601 Phone: 325-674-9494    Fax: 325-674-9493

Dr. Christopher S Eddleman, MD, PHD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1924 Pine St, Suite 504, Abilene, TX 79601 Phone: 325-670-4730    Fax: 325-670-4736

Dr. James Talmadge Trammell, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1850 Hickory St, Suite 101, Abilene, TX 79601 Phone: 325-670-4730    Fax: 325-670-4736

Dr. Quirico Umali Torres, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1101 N 19th St, Suite 103, Abilene, TX 79601 Phone: 325-677-9989

News Archive

Two MGH physicians describe their experiences in Nepal earthquake relief efforts

Two Massachusetts General Hospital physicians who participated in the international response to the major earthquakes that hit Nepal in April and May each describe their experiences in Perspectives articles receiving Online First publication today in the New England Journal of Medicine.

Latinos age more slowly than other ethnic groups, reveals UCLA study

A UCLA study is the first to show that Latinos age at a slower rate than other ethnic groups. The findings, published in the current issue of Genome Biology, may one day help scientists understand how to slow the aging process for everyone.

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.

Gene therapy succeeds in the second blind eye for three patients

Three people have now have reported a dramatic improvement in vision after having gene therapy in both eyes after having lost their eyesight as children.

Read more Medical News

› Verified 1 days ago